tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Cash flow

Compare
839 Followers

Immunovant Cash Flow

IMVT's free cash flow for Q4 2025 was $-110.84M. For the 2025 fiscal year, IMVT's free cash flow was decreased by $-162.05M and operating cash flow was $-110.64M. See a summary of the company’s cash flow.
Cash Flow
Mar 25Mar 24Mar 23Mar 22Mar 21
Operating Cash Flow
$ -375.87M$ -214.23M$ -188.19M$ -106.11M$ -83.33M
Investing Cash Flow
$ -759.00K$ -360.00K$ -197.00K$ -254.00K$ -210.00K
Financing Cash Flow
$ 454.49M$ 472.43M$ 70.89M$ 200.13M$ 383.11M
End Cash Position
$ 713.97M$ 635.37M$ 376.53M$ 493.82M$ 400.15M
Free Cash Flow
$ -376.63M$ -214.59M$ -188.39M$ -106.37M$ -83.54M
Currency in USD

Immunovant Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis